AUDIBLE Study: Evaluating ATUSA Ultrasound for Breast Lesions
This study, called AUDIBLE, is looking at a new way to image breast tissue using the ATUSA 3D Automated Breast Ultrasound System. It's for women aged 18 to 94 who have recently had suspicious breast imaging results (BI-RADS® 4 or 5, meaning a finding that is suspicious for cancer) and are scheduled for a biopsy. The study aims to collect images from the ATUSA system along with your medical records and biopsy results. The main goal is to see how many different types of breast imaging exams are collected from each participant over about six months. This is an observational study, meaning you won't receive a new treatment, but your existing care will be documented.
- Study design
- This is an observational study planning to include up to 800 female participants. It is not a randomized study.
- What's involved
- You would provide written consent and be available for the full study duration. The study will collect breast imaging examinations, information from your medical records, and biopsy outcomes from enrollment to about 180 days later.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your breast imaging examinations will be collected from enrollment up to approximately 180 days (about 6 months) after enrollment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Type and Number of breast imaging examinations collected per participantFrom Enrollment to +/- 180 days
The breast imaging exams (type and number) performed per patient (ATUSA, DBT, HHUS, MRI, and, if applicable, other exams such as FFDM) and number of biopsy-confirmed cancer cases.